Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

N Engl J Med. 2023 Jan 5;388(1):89-91. doi: 10.1056/NEJMc2214302. Epub 2022 Dec 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiviral Agents* / pharmacology
  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment*
  • COVID-19* / virology
  • Humans
  • SARS-CoV-2* / drug effects
  • Treatment Outcome

Substances

  • Antiviral Agents

Supplementary concepts

  • SARS-CoV-2 variants